#USA #biotechnology #Brussels #Sustainable Materials #AB4S

Unveiling the Future: The Molecule Manifesto by AB4S

The Advanced Biotech for Sustainability (AB4S) coalition has shifted gears from theoretical possibilities to concrete actions with the publication of its second annual report titled "The Molecule Manifesto." Launched on March 17, 2026, this significant report highlights the potential pathways to a staggering $1.1 trillion biotechnology economy through the commercial scaling of specific molecular families.

This year's focus diverges from the previous report’s economic inception, honing in instead on the practicalities of biotechnological execution. In their evaluations, the coalition examined an extensive array of over 300 distinct molecules within 40 different chemical families. After extensive research, they lighted upon four priority molecular families they deem the most promising for immediate commercial production: terpenes, peptides, non-catalytic proteins, and hydroxy acids.

Key Highlights of the Report

1. Terpenes and Terpenoids: The report claims these components hold the fastest route to market commercialization, with a potential valuation standing between $7 to $12 billion. Notably, industries revolving around fragrances and flavors are already welcoming bio-sourced terpenes at premium pricing, indicating a ripe market opportunity.

2. Bioactive Peptides: These versatile molecules reveal their market potential valued at an estimated $2.2 to $3.4 billion by 2030. Their broad applications range across cosmetics, agriculture, and food, appealing to an innovative need driven by regulatory frameworks. The desire for novel bioactive peptides significantly calls for biotechnology's advanced capabilities in their production.

3. Functional Proteins: Enabling key physical and biological functions such as foaming, gelling, and emulsification, these proteins promise a major market potential ranging from $21 to $31 billion as adoption expands. With precision fermentation paving the way for their production, functional proteins emerge as leading candidates to eliminate supply chain uncertainties, further stabilizing their market growth.

4. Hydroxy Acids: Offering unique integration within existing chemical infrastructures, hydroxy acids can be produced via fermentation and subsequently converted into high-volume derivatives leveraging established chemical processing methodologies. Excluding common commodities like citric or lactic acid, they present potential market opportunities estimated at $1.8 to $2 billion.

As these insights present a roadmap for progression, AB4S emphasized the urgency for enhanced cooperation and increased investments in the identified molecular families. This calls for concerted efforts, not only in terms of infrastructure financing but also in establishing cross-sector collaborations to facilitate the transition from pilot operations to full-fledged industrial scales.

CEO of Cradle, Stef van Grieken, underscores the urgency and significance of sustainable solutions, highlighting that artificial intelligence is already enhancing the invention pipeline, driving molecule market entry at accelerated paces while reducing costs. He points out that Europe's robust framework supporting sustainable materials and its impressive labor force could spearhead the development of novel industries benefiting society at large.

For further insights, the complete report can be accessed through the AB4S digital platform here.

About the AB4S Coalition

Founded in 2025, the Advanced Biotech for Sustainability (AB4S) coalition brings together influential organizations from various sectors, including established corporations, startups, and nonprofits. With eight founding members such as Arsenale Bioyards, Cradle, and L'Oréal, AB4S aims to unlock the substantial potential of advanced biotechnology, fostering innovative solutions through cross-industry collaboration and actionable recommendations. For more information on their initiatives or support for their mission, visit www.ab4s.org.